Compugen Ltd.
(NASDAQ : CGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.12%178.061.3%$463.32m
CELGCelgene Corporation
0.88%97.361.3%$421.81m
GILDGilead Sciences, Inc.
1.31%67.230.9%$393.59m
BIIBBiogen Inc.
2.09%232.421.3%$354.78m
ILMNIllumina, Inc.
2.06%351.103.5%$273.47m
REGNRegeneron Pharmaceuticals, Inc.
1.94%311.152.6%$233.42m
AAgilent Technologies, Inc.
0.59%70.381.6%$213.32m
VRTXVertex Pharmaceuticals Incorporated
2.19%173.951.9%$198.44m
ARRYArray BioPharma Inc.
57.11%46.498.2%$186.25m
EXASExact Sciences Corporation
0.92%110.7925.3%$184.56m
ALXNAlexion Pharmaceuticals, Inc.
2.21%120.542.0%$175.97m
BMRNBioMarin Pharmaceutical Inc.
4.23%84.264.3%$136.34m
MRTXMirati Therapeutics Inc.
6.82%100.692.5%$114.32m
IONSIonis Pharmaceuticals, Inc.
4.41%64.838.2%$97.20m
INCYIncyte Corporation
5.55%82.022.5%$92.14m

Company Profile

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.